Back

Feasibility, efficacity and safety of a fast up-titration program of heart failure treatments in real-life practice.

12 May 2024 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - treatment 3 Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Miss Laurine Blasi

Toulouse (France)

3 More presentations in this session

Presentation thumbnail
Analysis of the PARAGON-HF study results using win ratio
Doctor W. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Projected lifetime benefits of sacubitril/valsartan on event-free survival in patients with HFmrEF and HFpEF in the PARAGON-HF trial
Doctor A. Foa' (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Real-world impact of early quadruple therapy in HFrEF: a comparative analysis of sequential vs. simultaneous approaches
Mr D. Ferreira (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - treatment 3

The Event

Event poster

Heart Failure 2024

12 May 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Rapid up-titration of guideline-directed medical therapy in real-world clinical practice: initial experience of a heart failure outpatient clinic
thumbnail
Congress Presentation
Titration of guideline directed medical therapy in a high-risk heart failure patients and impact on heart failure events
thumbnail
Congress Presentation
Up-titration of Guideline Directed Medical Therapy (GDMT) and the occurrence of side effects in Heart Failure with reduced Ejection Fraction (HFrEF)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources